Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
The Relationship Between the Lifestyle of the Allogeneic Stem Cell Donors and the Number of Donated Cd34+ and Cd3+ Cells Publisher



L Sayadi LEILA ; S Mohammadi SAEED ; P Aminian PARIVASH
Authors

Source: International Journal of Hematology-Oncology and Stem Cell Research Published:2024


Abstract

Background: Hematopoietic stem cell transplantation (HSCT) is considered as the last treatment option in many life-threatening diseases. The number of donated cells can affect transplantation success. This study attempted to investigate the relationship between the health-promoting lifestyle of allogeneic stem cell donors and the number of donated CD34+ and CD3+ cells. Materials and Methods: The study was a descriptive correlational study in which 100 peripheral blood stem cells donors participated. A demographic form and health-promoting lifestyle profile-II questionnaire were distributed to participants, and then cell separation was started. Afterward, the results of CD34 + and CD3 + cell counts, as well as other clinical parameters of the participants, were recorded. The collected data were analyzed by descriptive and analytical statistical methods. Results: The results showed that the mean total health-promoting lifestyle profile score for hematopoietic stem cell donors was 2.876±0.461. There was no significant relationship between the health-promoting lifestyle score and the number of CD34+, CD3+ cells and CD3+/CD34+ ratio. A positive and significant correlation was found between the weight of the donors and the number of CD34+ (P < 0.001) and CD3+ cells (P = 0.001). The number of CD34+ cells was significantly different between women and men (P = 0.009). Conclusion: Lifestyle had no significant effect on the number of CD3+/CD34+ cells. Moreover, the number of CD34+ cells was significantly higher in men, so males should be preferentially recruited as donors for the HSCT procedure. © 2024 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Comparable Outcomes of Allogeneic Peripheral Blood Versus Bone Marrow Hematopoietic Stem Cell Transplantation in Major Thalassemia: A Multivariate Long-Term Cohort Analysis, Biology of Blood and Marrow Transplantation (2019)
2. How Do Anxiety Affect Cd34 and Cd3 Cells in Allogeneic Peripheral Blood Stem Cell Transplantation?, Transfusion and Apheresis Science (2018)
3. The Altered Expression of Homing Factors in Cd34+ Hematopoietic Stem Cells Following G-Csf Injection and Its Effects on Transplantation Quality in All Patients, Cell Biology International (2022)
Experts (# of related papers)
View all Related Experts
Amir Kasaeian (3)
Amir Ali Hamidieh (3)
Other Related Docs
4. Trends in Patient Outcome Over the Past Two Decades Following Allogeneic Stem Cell Transplantation for Acute Myeloid Leukaemia: An Alwp/Ebmt Analysis, Journal of Internal Medicine (2019)
5. The Complementary Role of Supportive and Palliative Care in Enhancing Bone Marrow Transplant Outcomes, Journal of Pain and Palliative Care Pharmacotherapy (2025)
6. Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Single-Center Study, Hematological Oncology (2017)
7. Physical Therapy Pathway and Protocol for Patients Undergoing Hematopoietic Stem Cell Transplantation: Recommendations From the Eastern Mediterranean Blood and Marrow Transplantation (Embmt) Group, Hematology/ Oncology and Stem Cell Therapy (2019)
8. Advances in Hematopoietic Stem Cell Transplantation in the Asia-Pacific Region: The Second Report From Apbmt 2005–2015, Bone Marrow Transplantation (2019)
9. Outcome of Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation As a Treatment Option in Patients With Severe Aplastic Anemia Between 40 and 50 Years, Hematology/ Oncology and Stem Cell Therapy (2022)
10. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged 70 Years and Older: A Systematic Review and Meta-Analysis, Transplantation and Cellular Therapy (2025)
11. Exploring the Financial Burden of Pediatric Bone Marrow Transplantation: A Cross-Sectional Study From the Caregiver’S Viewpoint, BMC Health Services Research (2025)
12. Long-Term Outcomes of Cord Blood Transplantation From an Hla-Identical Sibling for Patients With Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation, Biology of Blood and Marrow Transplantation (2017)
13. The Effect of Diabetes Mellitus Type2 on Mobilization and Autologous Hematopoietic Stem Cell Transplantation Outcomes, Indian Journal of Hematology and Blood Transfusion (2025)
14. Narrowing the Gap for Hematopoietic Stem Cell Transplantation in the East-Mediterranean/African Region: Comparison With Global Hsct Indications and Trends, Bone Marrow Transplantation (2019)
15. Peripheral Blood Stem Cell Apheresis in Low-Weight Children: A Single Centre Study, Transfusion and Apheresis Science (2019)
16. The Effect of Maternal and Infant Factors on Cord Blood Yield, Pediatric Blood and Cancer (2017)
17. Umbilical Cord Blood Quality and Quantity: Collection up to Transplantation, Asian Journal of Transfusion Science (2019)
18. Impact of Preexisting Diabetes Mellitus on Transplantation Outcomes in Hematopoietic Stem Cell Transplantation, Endocrine Research (2015)
19. First Report of Pediatric Hematopoietic Stem Cell Transplantation Activities in the Eastern Mediterranean Region From 1984 to 2011: On Behalf of the Pediatric Cancer Working Committee of the Eastern Mediterranean Blood and Marrow Transplantation Group, Bone Marrow Transplantation (2017)
20. The Effect of the Continuous Care on the Self-Care Behavior in Hematopoietic Stem Cell Transplantation (Hsct) Recipients: A Semi-Experimental Study, International Journal of Hematology-Oncology and Stem Cell Research (2022)